Últimos Artículos de Diabetes, Obesity and Metabolism
- Disentangling the relationship between glucose, insulin and brain health: A UK Biobank study
- Hepatic GCGR is required for the superior weight loss and metabolic effects of a structurally related analogue of the dual GCGR/GLP‐1R agonist survodutide in mice
- Impact of stepwise diabetes technology advances in older adults with type 1 diabetes: A systematic review and meta‐analysis of randomised trials
- Use of sodium‐glucose cotransporter‐2 inhibitors among older adults with type 2 diabetes mellitus in British Columbia
- Efficacy and safety of novel lipoprotein(a)‐targeted therapies: A systematic review and meta‐analysis of randomised controlled trials
- Efficacy and hypoglycaemia outcomes of once‐weekly insulin icodec versus once‐daily basal insulin comparators across baseline HbA1c, BMI and duration of type 2 diabetes subgroups: A post hoc analysis of ONWARDS 1–5
- Effectiveness and safety of saroglitazar in managing dyslipidaemia and liver enzymes in patients with type 2 diabetes, MASLD, and Stage 3 chronic kidney disease: A 12‐month observational study
- No causal link between the supply of GLP‐1 receptor agonists and antidepressants: Real‐world evidence from the Australian Pharmaceutical Benefits Scheme
- Explainable machine learning‐driven predictive modelling of incident cognitive impairment in individuals with early‐stage cardiovascular–kidney–metabolic syndrome: Insights from a longitudinal CHARLS cohort study
- Aldosterone antagonist combined with a SGLT2 inhibitor versus SGLT2 inhibitor monotherapy: An updated meta‐analysis
- Clinical implications of intentional weight loss in people living with type 2 diabetes: A real‐world database study
- Hypobaric hypoxia disrupts brown adipose thermogenic function in mice via Plin2 upregulation
- Correction to “An SGLT2 inhibitor, canagliflozin, reduces blood glucose level in the renal capillaries and protects the capillary network in the diabetic rats”
- CGM‐derived average glucose is more strongly associated with microvascular complications than HbA1c in type 1 diabetes
- Income‐related inequities in the progression from gestational to type 2 diabetes: Findings from Taiwan's maternal and child health database
- Sodium‐glucose cotransporter 2 inhibitor ameliorates thiazolidinedione‐induced fluid retention through vascular leakage reduction in white adipose tissue
- Immunogenicity, efficacy and safety of a biosimilar insulin glulisine compared with originator in adults with type 1 diabetes mellitus: A phase III randomised clinical trial
- Fluorescent but flawed: Fluorescent labelling alters brain distribution of intranasally administered insulin
- Comment on “Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin–activin–follistatin–IGF‐1 axis”
- Meta‐analysis of clinically available pharmacotherapy of biopsy confirmed metabolic dysfunction associated steatohepatitis (MASH)